160 related articles for article (PubMed ID: 33477555)
1. Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification.
Wang H; Li L; Ye J; Dong W; Zhang X; Xu Y; Hu J; Wang R; Xia X; Yang Y; Jin D; Wang R; Song Z; Gao L; Liu Y
Molecules; 2021 Jan; 26(2):. PubMed ID: 33477555
[TBL] [Abstract][Full Text] [Related]
2. Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates.
Wang H; Li L; Ye J; Wang R; Wang R; Hu J; Wang Y; Dong W; Xia X; Yang Y; Gao Y; Gao L; Liu Y
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028734
[TBL] [Abstract][Full Text] [Related]
3. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
[TBL] [Abstract][Full Text] [Related]
4. CAT
Ji M; Wang L; Chen J; Xue N; Wang C; Lai F; Wang R; Yu S; Jin J; Chen X
Onco Targets Ther; 2018; 11():3671-3684. PubMed ID: 29983575
[TBL] [Abstract][Full Text] [Related]
5. Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System.
Sun C; Li W; Zhang H; Adu-Frimpong M; Ma P; Zhu Y; Deng W; Yu J; Xu X
AAPS PharmSciTech; 2021 Jan; 22(1):45. PubMed ID: 33439366
[TBL] [Abstract][Full Text] [Related]
6. Novel Drug Delivery Approach via Self-Microemulsifying Drug Delivery System for Enhancing Oral Bioavailability of Asenapine Maleate: Optimization, Characterization, Cell Uptake, and In Vivo Pharmacokinetic Studies.
Patel MH; Mundada VP; Sawant KK
AAPS PharmSciTech; 2019 Jan; 20(2):44. PubMed ID: 30617712
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of a promising anti-brain tumor agent CAT3 and its two major metabolites in mouse plasma and brain by a LC-MS/MS method.
Zhao S; Wang RB; Bai J; Fan X; Hu M; Wang B; Hu J; Li Y
J Pharm Biomed Anal; 2020 Mar; 181():113106. PubMed ID: 31962248
[TBL] [Abstract][Full Text] [Related]
8. Self-microemulsifying Drug Delivery System for Improved Oral Delivery of Limonene: Preparation, Characterization, in vitro and in vivo Evaluation.
Zhu Y; Xu W; Zhang J; Liao Y; Firempong CK; Adu-Frimpong M; Deng W; Zhang H; Yu J; Xu X
AAPS PharmSciTech; 2019 Mar; 20(4):153. PubMed ID: 30915610
[TBL] [Abstract][Full Text] [Related]
9. Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation.
Patel MH; Sawant KK
Eur J Pharm Sci; 2019 Oct; 138():105027. PubMed ID: 31377133
[TBL] [Abstract][Full Text] [Related]
10. Development of Self-Microemulsifying Drug Delivery System to Improve Nisoldipine Bioavailability: Cell Line and In Vivo Evaluations : Development of Self-Microemulsifying Drug Delivery System.
Mundada VP; Patel MH; Mundada PK; Sawant KK
AAPS PharmSciTech; 2021 Oct; 22(8):256. PubMed ID: 34676456
[TBL] [Abstract][Full Text] [Related]
11. Improving The Oral Absorption Of Nintedanib By A Self-Microemulsion Drug Delivery System: Preparation And In Vitro/In Vivo Evaluation.
Liu H; Mei J; Xu Y; Tang L; Chen D; Zhu Y; Huang S; Webster TJ; Ding H
Int J Nanomedicine; 2019; 14():8739-8751. PubMed ID: 31806968
[TBL] [Abstract][Full Text] [Related]
12. The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts.
Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X
Int J Oncol; 2015 Jul; 47(1):179-87. PubMed ID: 25936609
[TBL] [Abstract][Full Text] [Related]
13. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.
Kamboj S; Rana V
Int J Pharm; 2016 Mar; 501(1-2):311-25. PubMed ID: 26854426
[TBL] [Abstract][Full Text] [Related]
14. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
15. Supersaturable self-microemulsifying delivery systems: an approach to enhance oral bioavailability of benzimidazole anticancer drugs.
Rosso A; Almouazen E; Pontes J; Andretto V; Leroux M; Romasko E; Azzouz-Maache S; Bordes C; Coste I; Renno T; Giraud S; Briancon S; Lollo G
Drug Deliv Transl Res; 2021 Apr; 11(2):675-691. PubMed ID: 33738676
[TBL] [Abstract][Full Text] [Related]
16. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A.
Zhu Z; Liu J; Yang Y; Adu-Frimpong M; Ji H; Toreniyazov E; Wang Q; Yu J; Xu X
J Microencapsul; 2021; 38(7-8):459-471. PubMed ID: 34338606
[TBL] [Abstract][Full Text] [Related]
17. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment.
Chen Y; Li G; Wu X; Chen Z; Hang J; Qin B; Chen S; Wang R
Biol Pharm Bull; 2008 Jan; 31(1):118-25. PubMed ID: 18175953
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Oral Bioavailability of Pueraria Flavones by a Novel Solid Self-microemulsifying Drug Delivery System (SMEDDS) Dropping Pills.
Guan Q; Zhang G; Sun S; Fan H; Sun C; Zhang S
Biol Pharm Bull; 2016 May; 39(5):762-9. PubMed ID: 26935150
[TBL] [Abstract][Full Text] [Related]
19. The preparation and investigation of spinosin-phospholipid complex self-microemulsifying drug delivery system based on the absorption characteristics of spinosin.
Song P; Lai C; Xie J; Zhang Y
J Pharm Pharmacol; 2019 Jun; 71(6):898-909. PubMed ID: 30784084
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
Nekkanti V; Rueda J; Wang Z; Betageri GV
Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
